SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Cars.com
CARS
Hutchmed (China)
HCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 110.52%24.45M | 144.59%67.23M | 154.19%27.08M | 373.33%16.51M | 18.78%12.04M | 261.18%11.61M | 93.08%27.49M | 10.21%10.65M | 278.36%3.49M | 440.09%10.13M |
Net income from continuing operations | 70.50%-4.52M | 53.88%-32.02M | 94.80%-597K | 62.03%-6.89M | 53.36%-9.21M | 23.60%-15.32M | 30.35%-69.43M | 46.87%-11.47M | 36.85%-18.15M | 18.46%-19.75M |
Depreciation and amortization | 11.83%5.75M | 7.65%21.49M | 18.15%5.96M | 10.20%5.26M | 7.89%5.13M | -4.64%5.14M | 19.21%19.96M | 19.14%5.04M | 9.67%4.78M | 15.79%4.75M |
Deferred tax | 57.52%-48K | 97.59%-22K | 165.65%302K | 27.70%-107K | 28.77%-104K | 28.48%-113K | 78.48%-912K | ---460K | ---148K | ---146K |
Other non cash items | 30.65%-966K | -43,485.71%-3.05M | -69.53%-1.44M | 187.56%528K | -89.09%-745K | -175.71%-1.39M | 99.76%-7K | 64.18%-850K | -390.24%-603K | -177.87%-394K |
Change In working capital | -10.30%3.69M | 87.69%17.23M | 92.27%11.34M | 213.01%2.12M | -106.98%-341K | 1,413.97%4.12M | -61.51%9.18M | -68.42%5.9M | -71.08%-1.88M | 260.21%4.89M |
-Change in receivables | 56.90%30.73M | 74.33%-7.78M | 45.25%-12.07M | 42.49%-2.5M | 24.52%-12.79M | 50.18%19.59M | -79.74%-30.3M | -40.26%-22.05M | 47.20%-4.35M | -78.36%-16.95M |
-Change in prepaid assets | -91.36%-2.57M | -555.19%-5.74M | -253.30%-1.61M | -187.98%-2.35M | -119.09%-446K | -2.68%-1.34M | 39.34%1.26M | 751.22%1.05M | -8.67%-815K | 447.07%2.34M |
-Change in payables and accrued expense | 28.53%-8.06M | 308.04%9.44M | -59.25%3.17M | 196.83%7.78M | 26.21%9.76M | 28.75%-11.28M | -85.16%2.31M | -42.25%7.79M | -54.68%2.62M | 328.90%7.73M |
-Change in other current liabilities | 74.94%-800K | 60.32%-2.88M | 120.92%819K | 90.36%-218K | -122.99%-291K | -35.60%-3.19M | -130.72%-7.26M | -305.68%-3.91M | -896.13%-2.26M | 91.24%1.27M |
-Change in other working capital | -4,650.44%-15.61M | -43.96%24.2M | -8.70%21.03M | -120.52%-600K | -67.37%3.43M | -94.89%343K | 57.74%43.17M | 21.92%23.03M | 61.28%2.92M | 31.80%10.5M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 110.52%24.45M | 144.59%67.23M | 154.19%27.08M | 373.33%16.51M | 18.78%12.04M | 261.18%11.61M | 93.08%27.49M | 10.21%10.65M | 278.36%3.49M | 440.09%10.13M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 7.23%-2.79M | -38.27%-19.83M | -62.87%-12.88M | -5.06%-2.14M | -23.55%-1.81M | -2.32%-3M | -96.79%-14.34M | -100.05%-7.91M | -59.11%-2.04M | -22.67%-1.46M |
Capital expenditure reported | 17.57%-1.53M | -15.82%-6.4M | 28.34%-1.18M | -49.62%-1.76M | -11.25%-1.59M | -47.00%-1.86M | -30.50%-5.52M | -39.54%-1.65M | -5.83%-1.18M | -29.27%-1.43M |
Net PPE purchase and sale | 68.97%-354K | -11.08%-2.46M | -361.39%-729K | -5.06%-374K | -610.00%-213K | 31.59%-1.14M | -299.28%-2.21M | 42.12%-158K | -115.76%-356K | 64.29%-30K |
Net business purchase and sale | ---897K | -66.16%-10.97M | ---- | ---- | ---- | --0 | -164.16%-6.6M | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 7.23%-2.79M | -38.27%-19.83M | -62.87%-12.88M | -5.06%-2.14M | -23.55%-1.81M | -2.32%-3M | -96.79%-14.34M | -100.05%-7.91M | -59.11%-2.04M | -22.67%-1.46M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,173.27%21.53M | -52.69%30.33M | -90.94%6.75M | 48,240.00%7.25M | 2,663.57%14.64M | 117.31%1.69M | 864.34%64.1M | 2,159.47%74.43M | 100.15%15K | -392.24%-571K |
Net issuance payments of debt | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net common stock issuance | ---- | --0 | ---- | ---- | ---- | ---- | -76.06%70.08M | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | 886.14%22.92M | 30.59%34.16M | -21.15%7.25M | -35.53%7.25M | 269.50%17.34M | 125.85%2.32M | 129.96%26.16M | 178.09%9.19M | 168.62%11.25M | 189.27%4.69M |
Net other financing activities | -119.12%-1.39M | 88.08%-3.83M | 89.67%-500K | --0 | 48.72%-2.7M | 94.14%-633K | -64.93%-32.14M | -48,310.00%-4.84M | 21.72%-11.23M | -202.82%-5.26M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,173.27%21.53M | -52.69%30.33M | -90.94%6.75M | 48,240.00%7.25M | 2,663.57%14.64M | 117.31%1.69M | 864.34%64.1M | 2,159.47%74.43M | 100.15%15K | -392.24%-571K |
Net cash flow | ||||||||||
Beginning cash position | 58.99%208.57M | 141.54%131.19M | 247.67%187.63M | 216.83%166.56M | 223.23%141.75M | 141.54%131.19M | 30.99%54.31M | 16.78%53.97M | -12.02%52.57M | -25.25%43.85M |
Current changes in cash | 319.30%43.19M | 0.62%77.73M | -72.86%20.94M | 1,373.62%21.62M | 207.01%24.87M | 208.55%10.3M | 468.16%77.25M | 756.87%77.17M | 110.95%1.47M | 1,323.55%8.1M |
Effect of exchange rate changes | 775.48%2.29M | 8.04%-343K | -93.88%3K | -673.24%-549K | -109.40%-58K | 126.96%261K | 50.13%-373K | 105.40%49K | 50.35%-71K | 19.11%617K |
End cash Position | 79.23%254.05M | 58.99%208.57M | 58.99%208.57M | 247.67%187.63M | 216.83%166.56M | 223.23%141.75M | 141.54%131.19M | 141.54%131.19M | 16.78%53.97M | -12.02%52.57M |
Free cash flow | 162.00%22.56M | 195.56%58.38M | 184.49%25.17M | 636.01%14.37M | 17.98%10.23M | 2,964.06%8.61M | 109.03%19.75M | 7.73%8.85M | 160.36%1.95M | 1,165.84%8.67M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |